LONG-TERM CLINICAL OUTCOMES ASSOCIATED WITH SEQUENTIAL TREATMENT OF BRAF MUTANT ADVANCED MELANOMA PATIENTS

被引：0
|
作者：
Tarhini, Ahmad [1 ]
McDermott, David [2 ,3 ]
Ambavane, Apoorva [4 ]
Benedict, Agnes [4 ]
Lee, Cho-Han [5 ]
Ritchings, Corey [5 ]
Stwalley, Brian [5 ]
Regan, Meredith [2 ,6 ]
Atkins, Michael [7 ]
机构：
[1] Moffitt Comprehens Canc Ctr & Res Inst, Tampa, FL USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Evidera, London, England
[5] Bristol Myers Squibb, Princeton, NJ USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0219
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
219
引用
收藏
页码：A130 / A131
页数：2
相关论文
共 50 条
  • [21] Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors
    Menzies, Alexander M.
    Wilmott, James S.
    Drummond, Martin
    Lo, Serigne
    Lyle, Megan
    Chan, Matthew M. K.
    Thompson, John F.
    Guminski, Alex
    Carlino, Matteo S.
    Scolyer, Richard A.
    Kefford, Richard F.
    Long, Georgina V.
    CANCER, 2015, 121 (21) : 3826 - 3835
  • [22] BRAF inhibitor rechallenge in patients with advanced BRAF V600-mutant melanoma
    Roux, Jennifer
    Pages, Cecile
    Malouf, Diane
    Seguin, Nicole Basset
    Madjlessi, Nika
    Baccard, Michel
    Comte, Christelle
    Archimbaud, Alain
    Battistella, Maxime
    Viguier, Manuelle
    Mourah, Samia
    Bagot, Martine
    Lebbe, Celeste
    MELANOMA RESEARCH, 2015, 25 (06) : 559 - 563
  • [23] BRAF inhibitor cessation prior to disease progression in metastatic melanoma: Long-term outcomes
    Lee, Joanna
    Ahmed, Tasnia
    Maurichi, Andrea
    Di Guardo, Lorenzo
    Stagno, Anna M.
    Warburton, Lydia
    Taylor, Amelia. M.
    Livingstone, Elisabeth
    Rehman, Saba
    Khattak, Adnan
    Kahler, Katharina C.
    Vanella, Vito
    Atkinson, Victoria
    Millward, Michael
    Schadendorf, Dirk
    Johnson, Douglas B.
    Ascierto, Paolo A.
    Hauschild, Axel
    Lo, Serigne N.
    Long, Georgina V.
    Menzies, Alexander M.
    Carlino, Matteo S.
    EUROPEAN JOURNAL OF CANCER, 2023, 179 : 87 - 97
  • [24] Sequencing of Targeted Treatment and Immunotherapy in Advanced BRAF-Mutant Melanoma
    Devlin, Olivia
    Oladipo, Olabode
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (12) : 2295 - +
  • [25] Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes
    Schouwenburg, Maartje G.
    Jochems, Anouk
    Leeneman, Brenda
    Franken, Margreet G.
    van den Eertwegh, Alfons J. M.
    Haanen, John B. A. G.
    van Zeijl, Michiel C. T.
    Aarts, Maureen J.
    van Akkooi, Alexander C. J.
    van den Berkmortel, Franchette W. P. J.
    Blokx, Willeke A. M.
    de Groot, Jan Willem B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Koornstra, Rutger H.
    Kruit, Wim H.
    Louwman, Marieke W. J.
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Suijkerbuijk, Karijn P. M.
    ten Tije, Albert J.
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    van der Hoeven, Jacobus J. M.
    MELANOMA RESEARCH, 2018, 28 (04) : 326 - 332
  • [26] Treatment reality of patients with BRAF-mutant advanced/metastatic melanoma in Switzerland in the era of choice
    Mangana, Joanna
    Zihler, Deborah
    Bossart, Simon
    Broennimann, Daniel
    Zachariah, Ralph
    Gerard, Camille Lea
    MELANOMA RESEARCH, 2022, 32 (05) : 366 - 372
  • [27] Treatment Sequencing in Advanced BRAF-Mutant Melanoma Patients: Current Practice in the United States
    Audibert, Celine
    Stuntz, Mark
    Glass, Daniel
    JOURNAL OF PHARMACY TECHNOLOGY, 2018, 34 (01) : 17 - 23
  • [28] Clinical presentation, treatment, and long-term outcomes in patients with takotsubo cardiomyopathy
    Opolski, Grzegorz
    Pawlak, Maciej M.
    Roik, Marek F.
    Kochanowski, Janusz
    Scislo, Piotr
    Piatkowski, Radoslaw
    Kochman, Janusz
    Karpinski, Grzegorz
    Kowalik, Robert
    Grabowski, Marcin
    Balsam, Pawel
    Filipiak, Krzysztof J.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2010, 120 (06): : 1 - 5
  • [29] Histopathologic and Clinical Features of Patients with BRAF Mutant Metastatic Melanoma
    Geszti, F.
    Serester, O.
    Plotar, V
    Toth, E.
    Liszkay, G.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 34 - 34
  • [30] Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma
    Handel, Eleanor E.
    Mckeown, Janet
    Wei, Joe
    Kankaria, Roma A.
    Burnette, Hannah
    Johnson, Douglas B.
    Lawless, Aleigha
    Czapla, Juliane
    Sullivan, Ryan J.
    Albrecht, Lea Jessica
    Zimmer, Lisa
    Mangana, Joanna
    Dummer, Reinhard
    Kessels, Jolien I.
    Neyns, Bart
    Allayous, Clara
    Lebbe, Celeste
    Boatwright, Christina
    Mehnert, Janice M.
    Ottaviano, Margaret
    Ascierto, Paolo A.
    Czarnecka, Anna M.
    Rutkowski, Piotr
    Lo, Serigne N.
    V. Long, Georgina
    Menzies, Alexander M.
    Carlino, Matteo S.
    EUROPEAN JOURNAL OF CANCER, 2025, 215
12345